RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @MartinQuirosMD: Uso compasivo de #remdesivir para #SARSCoV2. 61 pacientes. No grupo control... https://t.co/yox5H5bBPh
RT @lmorello_dc: A good sign - now we wait for the first data from randomized, controlled trials. https://t.co/yBR0TZ6R9f
RT @BogochIsaac: Early data for Remdesivir in the treatment of #COVID19. -53 patients with data -Baseline: 57% on mechanical ventilation,…
RT @BogochIsaac: Early data for Remdesivir in the treatment of #COVID19. -53 patients with data -Baseline: 57% on mechanical ventilation,…
Caveats: -only 18-day follow-up, so 13% mortality rate will go up; -oldest subject was only 72 yo when mortality goes really through roof >80yo. +should have plotted oxygen-status pre-dosing. $GILD #remdesivir
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @BogochIsaac: Early data for Remdesivir in the treatment of #COVID19. -53 patients with data -Baseline: 57% on mechanical ventilation,…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @antonioregalado: Report in NEJM on remdesivir in covid-19 patients. "compassionate use" cases. Authors think potentially helpful but do…
#Compassionate Use of #Remdesivir for #Patients with #Severe #COVID19 -19 | #NEJM $GILD, #Gilead #coronavirus #Corona #medicine @cnbc @megtirrell https://t.co/DZnGT6Q3HR
RT @BogochIsaac: Early data for Remdesivir in the treatment of #COVID19. -53 patients with data -Baseline: 57% on mechanical ventilation,…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
@VPrasadMDMPH and they pile in... Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/H5iAZ54Azw
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Early data for Remdesivir in the treatment of #COVID19. -53 patients with data -Baseline: 57% on mechanical ventilation, 8% ECMO -Compassionate use of drug, so no control group -Clinical improvement in 68% So does it work? Who knows... Trials underway
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Uso compasivo de #remdesivir para #SARSCoV2. 61 pacientes. No grupo control... https://t.co/yox5H5bBPh
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Remdesivir: possible improvement seen in patients with severe COVID-19, but no control group.
Remdesivir, an antiviral that was developed for Ebola and has shown effectiveness against SARS and MERS, is looking encouraging for #COVID19, but more data is necessary. Thread 👇🏻
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
RT @rcolvile: These results (passed on by a medic friend) are very preliminary - small sample, no control group etc. But a slim ray of hope…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
# COVID 19 Compassionate Use of Remdesivir for Patients with Severe Covid-19 https://t.co/pIADXzC0pB
RT @EdBelongia: Some encouraging news on remdesivir. This @NEJM analysis had no control group and is inconclusive, but outcomes were better…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @vote4dongshen: #BREAKING #coronavirus #Gilead @NEJM First report on #remdisivir In this cohort of patients hospitalized for severe Co…
RT @EMSwami: Interesting data on compassionate use Remdesivir in severe #COVID19 https://t.co/emNbrG4tVC Caution: not for all comers - Smal…
A good sign - now we wait for the first data from randomized, controlled trials.
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Clinical phase 2-like study #of Remdesivir showed hopeful results within 6 weeks. A controlled randomized phase 3 study will be performed soon. https://t.co/Jf4wiwZNSB
@politico Meanwhile... https://t.co/9Ivm1EXxFQ… @NEJM
RT @dr_michaelmarks: Conclusion Remdesivir #COVID19 @nejm https://t.co/oUKDAiA3SN Almost nil. >10% excluded analysis. No placebo/active com…
RT @neerajaiims: Just in @NEJM: Compassionate use of Remdesivir, a viral RNA polymerase inhibitor, results in clinical improvement in 68% h…
Lovende nye data omkring remdesivir. Bliver endnu mere spændende når det første af 2 placebo-kontrollerede studier fra Gilead kommer ud snart. Udfordringen bliver at lave dette stof i stor skala, det er ikke et nemt stof at syntetisere proceskemisk.
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @CMichaelGibson: Encouraging data for compassionate use of #Remdesivir in #coronavirus patients. 57% of those treated with extubated whi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @accpinfdprn: 📄 New today from @NEJM on @GileadSciences’s remdesivir for #COVID19 📲 https://t.co/LPlhryLTAW No comparator. 68% had cl…
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/FH3x4fqDu6
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Remdesvir in #COVID
RT @cristian_marti: Remdesivir
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
REMDESIVIR como tratamiento de #COVIDー19, un análisis de su uso compasivo se publicó en el @NEJM hoy. ¿Qué podríamos concluir de él? https://t.co/PopjJTYEvL
Uncontrolled study of remdesivir for severe Covid-19. Already some are saying, given the “favorable” outcomes, unethical to continue randomized trials. Predictable, but incredibly dangerous. https://t.co/jgEYA8ERuA
RT @davidrliu: Encouraging clinical results from remdesivir to treat very ill #COVID19 patients. Next: randomized, blinded, controlled tria…
RT @FogelOlivier: Use of Remdesivir for Patients with Severe Covid-19 | @NEJM @COVID19 https://t.co/GI5kTK1hx5
RT @CarlosdelRio7: Compassionate Use of Remdesivir for Patients with Severe #COVIDー19 | @NEJM in this cohort of patients benefits were ob…
well, it looks like my friend @EMSwami saved me the trouble! Thank you for the great summary, friend: https://t.co/X91olv5M79
RT @andersskyrud: Hva skal liksom denne studien tilføre, og hvorfor er den publisert i NEJM? Den har ikke kontroll-arm og ville nesten uans…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
These results (passed on by a medic friend) are very preliminary - small sample, no control group etc. But a slim ray of hope. Same drug currently being trialled in various centres in UK - fingers crossed for similar findings... https://t.co/rAdnZiDXED
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
Compassionate Use of Remdesivir for Patients with Severe Covid-19 | NEJM https://t.co/Omg5Qkpa4R
RT @pnatarajanmd: Among 53 patients hospitalized for #COVID19 with hypoxia who received compassionate use remdesivir, 36 (68%) experienced…
Thread: Remdesivir might help
RT @Nat_anest: В NEJM сегодня опубликовали первый отчёт о применении Ремдесивира 53-и пациентам с тяжёлым течение Covid. Клиническое улучше…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @ahmedjo70s: يالله يا ولاد خبر كويس أهو..ال Remdesivir بتاع جليد..الشركة اللي عملت أدوية ڤيروس سي..جايب نتيجة كويسة في الحالات الحادة ..…
RT @FogelOlivier: Use of Remdesivir for Patients with Severe Covid-19 | @NEJM @COVID19 https://t.co/GI5kTK1hx5
RT @jsmadero: Uso abierto de remdesivir en pac con enfermedad grave por Covid-19. Mortalidad 18% en pac con ventilación mecánica. Compassi…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @malkadav: Premiers résultats encourageants de l’antiviral #remdesivir pour le #covid19, en particulier et y compris dans les cas sévère…
#BREAKING #coronavirus #Gilead @NEJM First report on #remdisivir In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). https://t.co/OD
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @KiraNewmanMDPhD: Compassionate #remdisivir use (n=53) encouraging but doesn’t prove benefit in #COVID19. •Use criteria: O2 sat<94%, Cr…
RT @EMSwami: Interesting data on compassionate use Remdesivir in severe #COVID19 https://t.co/emNbrG4tVC Caution: not for all comers - Smal…
RT @AndyBiotech: NEJM report on compassionate use of Remdesivir for 53 patients with severe #COVID19 https://t.co/gL0QKtw39L … 36/53 (68%)…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
RT @davidrliu: Encouraging clinical results from remdesivir to treat very ill #COVID19 patients. Next: randomized, blinded, controlled tria…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @laoneill111: First study on resdemivir (anti-viral) in COVID19. Eminent journal (NEJM). Very sick patients on ventilation 13% fatality…
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
RT @EricTopol: Big for #COVID19 therapy: the compassionate use results for remdesivir in 53 patients looks very encouraging, especially in…
RT @StearnsLab: A Gilead drug, GS-5734 (remdesivir) was approved in mid-March for compassionate use in severe #COVID19 cases. Some data are…
Results of compassionate use for remdesivir in severe COVID-19 patients released by @GileadSciences . "36 patients (68%) had an improvement in oxygen-support class, including 17 of 30 patients (57%) receiving mechanical ventilation who were extubated." ht
Ok. Very ill patients. Now we need a control group, and longer follow-up data. Waiting for #Discovery study results. But there may be something there. #remdisivir #SARSCoV2 #COVIDー19 #NEJM https://t.co/fCMEQVkJwz
Compassionate Use of Remdesivir for Patients with Severe Covid-19 https://t.co/eRWv470Phe
Remdesivir still looks promising.🧪🧫